2019
Author Correction: Genome-wide association study of alcohol consumption and use disorder in 274,424 individuals from multiple populations
Kranzler HR, Zhou H, Kember RL, Smith RV, Justice AC, Damrauer S, Tsao PS, Klarin D, Baras A, Reid J, Overton J, Rader DJ, Cheng Z, Tate JP, Becker WC, Concato J, Xu K, Polimanti R, Zhao H, Gelernter J. Author Correction: Genome-wide association study of alcohol consumption and use disorder in 274,424 individuals from multiple populations. Nature Communications 2019, 10: 2275. PMID: 31101824, PMCID: PMC6525240, DOI: 10.1038/s41467-019-10254-5.Peer-Reviewed Original Research
2010
Comparative Effectiveness Research
Concato J, Peduzzi P, Huang G, O'Leary T, Kupersmith J. Comparative Effectiveness Research. Journal Of Investigative Medicine 2010, 58: 764. DOI: 10.2310/jim.0b013e3181e3d2af.Peer-Reviewed Original ResearchComparative effectiveness researchVA electronic medical record systemProton pump inhibitor medicationVeterans AffairsBenefits of clopidogrelOptimal medical therapyAcute coronary syndromeCoronary artery bypassDifferent therapeutic optionsPercutaneous coronary interventionEffectiveness researchElectronic medical record systemPatient-oriented researchVA trialArtery bypassCoronary syndromeCoronary interventionMedical record systemInhibitor medicationMedical therapyTherapeutic optionsClinical trialsObservational studyHealth outcomesStudy design